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Introduction. It is known that leukotrienes (LT) are considered not only as 
mediators of formation of the gastric and duodenal lesions but also as mediators 
of the constant inflammation in the periulcerous zone [1, 3, 4, 7, 8]. Local and 
systemic modulating effects of LT, their influence upon the initiation of 
production of the platelet activating factors and neutrophils binding factors [6, 
10], the formation of superoxide anions, the release of lysosomal enzymes [2, 5, 
9] and their direct participation in the inflammatory process let us suggest that 
the level and the character of dynamics of LT change are some of the possible 
indicators of the inflammatory process’ treatment efficiency and prognosis of 
the course of the disease. We did not exclude the possibility of the comorbid 
pathology influences upon the quantitative and qualitative changes of 
biologically active substances and metabolic indices. It was the ground for 
carrying out the present study. The aim of the research was to study the 
dynamics of lipoxygenase metabolites of the arachidonic acid content and 
lipoperoxidation activity before treatment and during the early period after 
carrying out the basic therapeutic course in the patients with duodenal peptic 
ulcer and comorbid essential hypertension.  
Materials and methods. The group of the examined individuals included 54 
patients with duodenal peptic ulcer aged 38-49 years, among whom 33 patients 
had the comorbid essential hypertension. The determination of LTB4 and LTC4 
content in the blood serum was carried out by the radioimmune method (an 
assay kit «LTB4», «LTC4/B4/D4», Amersham, Great Britain), the level of 
malondialdehyde (MDA) in the blood serum was studied by means of 
spectrophotometry. The reference indices were obtained in 21 practically 
healthy individuals (the control group). They and the examined patients were of 
the same sex and age. Mathematical processing of the results was carried out by 
means of variation statistics methods using the application programs package 
Statistika 6.0.  
Results. A significant increase of LTB4 and LTC4 in the blood serum of the 
patients with duodenal peptic ulcer and comorbid essential hypertension in 
comparison with the control group was revealed during the initial study. These 
indices were, accordingly, 217.1±22.9 pg/ml (the control group - 53.2±11.4 
pg/ml, р<0.001) and 211.1±24.7 pg/ml (the control group - 39.7±10.8 pg/ml, 
р<0.001). Besides, these indices of the patients with the comorbid pathology 
weren’t different significantly in comparison with the ones of the patients with 
the isolated duodenal peptic ulcer (215.2±24.7 pg/ml and 191.5±27.5 pg/ml, 
accordingly). MDA content in the blood serum of the patients of both examined 
groups was equal and 2.3 times as high as among the reference norm (the 
control group - 4.88±0.18 mcmol/l, р<0.001). The repeated (after the main 
treatment course) study of the LT content in the blood serum of the examined 
patients with duodenal peptic ulcer showed a decrease of LTB4 (to 89.5±19.4 
pg/ml) and LTC4 (to 66.1±20.8 pg/ml) content, in 2.4 (р<0.01) and 2.9 (р<0.05) 
times, accordingly. At the same time it was established that dynamics of 
decrease of the LTB4 (to121.9±19.8 pg/l) and the LTC4 (to 109.1±18.6 pg/l) 
content in the patients with the comorbid pathology was significant 
(accordingly, in 1.98 and 1.93 times, р<0.01) but less than that one among the 
patients with the isolated pathology. It is to mention that significance of 
differences of LTB4 and LTC4 in the patients with duodenal peptic ulcer after the 
treatment in comparison with the control group wasn’t revealed but these indices 
among patients with the comorbid pathology were higher and significance of 
differences in comparison with reference norm was established (accordingly, 
р<0.01 и р<0.05). It is necessary also to mention that dynamics of the decrease 
of MDA content after treatment in examined patients was significant (р<0.001). 
But it was less significant in the patients with the comorbid pathology (in 1.23 
times, 9.28±0.42 mcmol/l) in comparison with the patients with the isolated 
duodenal peptic ulcer (in 1.45 times, 7.06±0.39 mcmol/l). Thus, the foregoing 
assumes the following conclusions. 
Conclusion. A significant increase of leukotrienes synthesis and activation 
of lipoperoxidation processes occur in the patients with duodenal peptic ulcer 
and comorbid essential hypertension. The dynamics of decrease of the 
leukotrienes content during the early period of the treatment in the patients with 
the comorbid pathology is less significant than among the patients with the 
isolated duodenal peptic ulcer; besides, the high activity of lipid peroxidation 
processes can be considered as a factor of the course of disease’s worsening. 
Prospects for further research. The dynamics of the change of the 
leukotrienes content and the lipid peroxidation activity during the early period of 
the treatment of the patients with duodenal peptic ulcer in combination with 
essential hypertension suggests clarification of pathogenetic mechanisms of their 
synthesis’ activation and determines the search of the possible ways of the 
revealed disorders’ correction.  
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